- Advertisement -Newspaper WordPress Theme
InvestmentsTheranos founder Elizabeth Holmes begins defense case By Reuters

Theranos founder Elizabeth Holmes begins defense case By Reuters


© Reuters. FILE PHOTO: Former Theranos CEO Elizabeth Holmes arrives for a listening to at a federal court docket in San Jose, California, U.S., July 17, 2019. REUTERS/Stephen Lam/File Photo

By Jody Godoy

SAN JOSE, Calif. (Reuters) -Lawyers for Theranos founder Elizabeth Holmes started to current witnesses in her defense towards fraud fees on Friday, but it surely remained unclear whether or not the previous Silicon Valley govt who as soon as promised to revolutionize the blood testing trade would testify.

Over the course of the two-month trial, jurors in San Jose, California, have heard testimony from greater than two dozen witnesses for the prosecution, together with sufferers and buyers whom prosecutors say Holmes deceived. At the shut of their case, prosecutors moved to dismiss one rely of fraud concerning a affected person.

Holmes’ defense attorneys started by calling paralegal Trent Middleton to the stand to supply summaries of Theranos paperwork.

They have mentioned additionally they plan to name Fabrizio Bonanni, who joined Theranos as a director in 2016. Bonanni will testify concerning the firm’s know-how, they mentioned in court docket.

Defense lawyer Lance Wade informed jurors throughout opening arguments in September that Holmes was a hardworking younger entrepreneur who had underestimated the obstacles Theranos confronted earlier than it failed.

Holmes is accused of creating false claims about Theranos, together with that its units might run a spread of assessments extra rapidly and precisely than standard laboratory means from a drop of blood from a finger prick.

Once touted because the Steve Jobs of biotech for her firm’s supposedly modern know-how, Holmes faces 9 counts of wire fraud and two counts of conspiracy. She has pleaded not responsible.

Founded by Holmes on the age of 19 in 2003, Theranos garnered consideration from personal buyers and was as soon as valued at $9 billion.

Its fortunes waned after the Wall Street Journal revealed a sequence of articles beginning in 2015 that prompt the Theranos units have been flawed and inaccurate.

Disclaimer: Fusion Media want to remind you that the info contained on this web site shouldn’t be essentially real-time nor correct. All CFDs (shares, indexes, futures) and Forex costs should not supplied by exchanges however relatively by market makers, and so costs is probably not correct and will differ from the precise market value, which means costs are indicative and never applicable for buying and selling functions. Therefore Fusion Media doesn`t bear any accountability for any buying and selling losses you would possibly incur because of utilizing this information.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or harm because of reliance on the knowledge together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding varieties doable.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Exclusive content

- Advertisement -Newspaper WordPress Theme

Latest article

More article

- Advertisement -Newspaper WordPress Theme